Search research articles
Contact Us
Filters
Showing results (331-340 of 400) with videos related to
Page
of 40
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 14, 2017
Predictive Value of <sup>18</sup>F-FDG PET in Patients with Advanced Medullary Thyroid Carcinoma Treated with Vandetanib
Rudolf A Werner, Jan-Stefan Schmid, Takahiro Higuchi, et al.
Pharmaceuticals (Basel, Switzerland)
|
June 1, 2023
BET Bromodomain Degradation Disrupts Function but Not 3D Formation of RNA Pol2 Clusters
Diana H Chin, Issra Osman, Jadon Porch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 3, 2008
Early metabolic response evaluation by fluorine-18 fluorodeoxyglucose positron emission tomography allows in vivo testing of chemosensitivity in gastric cancer: long-term results of a prospective study
Katja Ott, Ken Herrmann, Florian Lordick, et al.
Annals of Clinical and Translational Neurology
|
September 15, 2017
Cholinergic activity and levodopa-induced dyskinesia: a multitracer molecular imaging study
Joachim Brumberg, Sebastian Küsters, Ehab Al-Momani, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 7, 2024
Prognostic Performance of RECIP 1.0 Based on [<sup>18</sup>F]PSMA-1007 PET in Prostate Cancer Patients Treated with [<sup>177</sup>Lu]Lu-PSMA I&T
Philipp E Hartrampf, Thomas Hüttmann, Anna Katharina Seitz, et al.
British Journal of Haematology
|
August 16, 2005
188Re or 90Y-labelled anti-CD66 antibody as part of a dose-reduced conditioning regimen for patients with acute leukaemia or myelodysplastic syndrome over the age of 55: results of a phase I-II study
Mark Ringhoffer, Norbert Blumstein, Bernd Neumaier, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
May 29, 2021
Targeting fibroblast activation protein in newly diagnosed squamous cell carcinoma of the oral cavity - initial experience and comparison to [<sup>18</sup>F]FDG PET/CT and MRI
Christian Linz, Roman C Brands, Olivia Kertels, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
November 9, 2023
Chemokine receptor-targeted PET/CT provides superior diagnostic performance in newly diagnosed marginal zone lymphoma patients: a head-to-head comparison with [<sup>18</sup>F]FDG
Aleksander Kosmala, Johannes Duell, Simone Schneid, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
January 20, 2023
[<sup>18</sup>F]FET-PET in children and adolescents with central nervous system tumors: does it support difficult clinical decision-making?
Olivia Kertels, Jürgen Krauß, Camelia Maria Monoranu, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 8, 2018
Interobserver Agreement for the Standardized Reporting System PSMA-RADS 1.0 on <sup>18</sup>F-DCFPyL PET/CT Imaging
Rudolf A Werner, Ralph A Bundschuh, Lena Bundschuh, et al.
Page
of 40
Search research articles
Search
Showing results (331-340 of 400) with videos related to
Sort By:
Page
of 40
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 14, 2017
Predictive Value of <sup>18</sup>F-FDG PET in Patients with Advanced Medullary Thyroid Carcinoma Treated with Vandetanib
Rudolf A Werner, Jan-Stefan Schmid, Takahiro Higuchi, et al.
Pharmaceuticals (Basel, Switzerland)
|
June 1, 2023
BET Bromodomain Degradation Disrupts Function but Not 3D Formation of RNA Pol2 Clusters
Diana H Chin, Issra Osman, Jadon Porch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 3, 2008
Early metabolic response evaluation by fluorine-18 fluorodeoxyglucose positron emission tomography allows in vivo testing of chemosensitivity in gastric cancer: long-term results of a prospective study
Katja Ott, Ken Herrmann, Florian Lordick, et al.
Annals of Clinical and Translational Neurology
|
September 15, 2017
Cholinergic activity and levodopa-induced dyskinesia: a multitracer molecular imaging study
Joachim Brumberg, Sebastian Küsters, Ehab Al-Momani, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 7, 2024
Prognostic Performance of RECIP 1.0 Based on [<sup>18</sup>F]PSMA-1007 PET in Prostate Cancer Patients Treated with [<sup>177</sup>Lu]Lu-PSMA I&T
Philipp E Hartrampf, Thomas Hüttmann, Anna Katharina Seitz, et al.
British Journal of Haematology
|
August 16, 2005
188Re or 90Y-labelled anti-CD66 antibody as part of a dose-reduced conditioning regimen for patients with acute leukaemia or myelodysplastic syndrome over the age of 55: results of a phase I-II study
Mark Ringhoffer, Norbert Blumstein, Bernd Neumaier, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
May 29, 2021
Targeting fibroblast activation protein in newly diagnosed squamous cell carcinoma of the oral cavity - initial experience and comparison to [<sup>18</sup>F]FDG PET/CT and MRI
Christian Linz, Roman C Brands, Olivia Kertels, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
November 9, 2023
Chemokine receptor-targeted PET/CT provides superior diagnostic performance in newly diagnosed marginal zone lymphoma patients: a head-to-head comparison with [<sup>18</sup>F]FDG
Aleksander Kosmala, Johannes Duell, Simone Schneid, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
January 20, 2023
[<sup>18</sup>F]FET-PET in children and adolescents with central nervous system tumors: does it support difficult clinical decision-making?
Olivia Kertels, Jürgen Krauß, Camelia Maria Monoranu, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 8, 2018
Interobserver Agreement for the Standardized Reporting System PSMA-RADS 1.0 on <sup>18</sup>F-DCFPyL PET/CT Imaging
Rudolf A Werner, Ralph A Bundschuh, Lena Bundschuh, et al.
Page
of 40